A Study of Psilocybin for Major Depressive Disorder (MDD)
Condition(s):Depressive Disorder, MajorLast Updated:June 5, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Depressive Disorder, MajorLast Updated:June 5, 2023Completed
Condition(s):Major Depressive DisorderLast Updated:November 29, 2023Recruiting
Condition(s):Major Depressive Disorder; Alcohol Use DisorderLast Updated:December 5, 2023Recruiting
Condition(s):Major Depressive DisorderLast Updated:October 15, 2021Unknown status
Condition(s):Depressive Disorder, MajorLast Updated:March 26, 2024Recruiting
Condition(s):Treatment Resistant Depression; MDD; Major Depressive Disorder; Recurrent Depression; DepressionLast Updated:November 18, 2023Not yet recruiting
Condition(s):Depressive Disorder, MajorLast Updated:July 31, 2020Unknown status
Condition(s):Treatment-resistant DepressionLast Updated:October 5, 2023Active, not recruiting
Condition(s):Major Depressive DisorderLast Updated:March 25, 2024Completed
Condition(s):Major Depressive DisorderLast Updated:April 25, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.